Parexel, a provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, has appointed Clare Grace, Ph.D., as the company’s first chief patient officer. The appointment reflects the role of the patient as central to the company’s mission of keeping patients at the heart of all clinical trial activity.   “Patients are at the heart of everything we do,” said Sy Pretorius, MD, Chief Medical and Scientific Officer at Parexel. “Clare’s proven track ...